Swipe om te navigeren naar een ander artikel
To evaluate the psychometric properties of the Profile of Mood States (POMS) in postmenopausal women with moderate to severe vasomotor symptoms.
Internal consistency, validity, and reliability of the POMS were examined using blinded data from 539 postmenopausal women with ≥50 moderate to severe hot flushes per week at baseline enrolled in a multicenter, randomized, double-blind, placebo-controlled study of the efficacy and safety of desvenlafaxine (administered as desvenlafaxine succinate) for vasomotor symptoms.
The POMS subscales and total score demonstrated sound internal consistency reliability (α ≥ 0.84). Comparisons between POMS subscales and Total Mood Disturbance (TMD) scores with Greene Climacteric Scale domains provided consistent known-groups and construct validity. Results from the confirmatory factor analysis were supportive of the second-order factor structure (root-mean-square error of approximation = 0.078). For women with POMS TMD scores below the US adult female norms, there was little mean change at Week 12 but marked mean improvement in women with greater mood symptoms scoring worse than the norm at baseline.
These data demonstrate the internal consistency and validity of the POMS to measure mood among postmenopausal women with moderate to severe hot flushes and the responsiveness of the POMS among these women with greater mood symptoms.
Log in om toegang te krijgen
Met onderstaand(e) abonnement(en) heeft u direct toegang:
McNair, D. M., Lorr, M., & Droppleman, L. F. (1992). EDITS manual profile of mood states. San Diego: Educational and Industrial Testing Service.
McNair, D. M., Heuchert, J. W. P., & Shilony, E. (2003). Profile of mood states bibliography 1964–2002. Toronto, Canada: Multi-Health Systems.
Banger, M., Rimpel, J., Lodemann, E., Feldmann, H. U., & Gastpar, M. (1999). Self-assessment of somatic and psychic symptoms during a two months period of hormone replacement therapy in perimenopausal women. Archives of Women’s Mental Health, 1(4), 183–187. CrossRef
Miller, K. J., Conney, J. C., Rasgon, N. L., Fairbanks, L. A., & Small, G. W. (2002). Mood symptoms and cognitive performance in women estrogen users and nonusers and men. Journal of the American Geriatric Society, 50(11), 1826–1830. CrossRef
Barton, D. L., Loprinzi, C. L., Novotny, P., Shanafelt, T., Sloan, J., Wahner-Roedler, D., et al. (2003). Pilot evaluation of citalopram for the relief of hot flashes. Journal of Supportive Oncology, 1(1), 47–51. PubMed
Slaven, L., & Lee, C. (1994). Psychological effects of exercise among adult women: The impact of menopausal status. Psychology & Health, 9(4), 297–303. CrossRef
Allen, S. S., Hatsukami, D. K., & Christianson, D. (2003). Nicotine withdrawal and depressive symptomatology during short-term smoking abstinence: A comparison of postmenopausal women using and not using hormone replacement therapy. Nicotine & Tobacco Research, 5(1), 49–59. CrossRef
Allen, S. S., Hatsukami, D. K., Bade, T., & Center, B. (2004). Transdermal nicotine use in postmenopausal women: Does the treatment efficacy differ in women using and not using hormone replacement therapy? Nicotine & Tobacco Research, 6(5), 777–788. CrossRef
Archer, D. F., Dupont, C. M., Constantine, G. D., Pickar, J. H., & Olivier, S. (2009). Desvenlafaxine for the treatment of vasomotor symptoms associated with menopause: A double-blind, randomized, placebo-controlled trial of efficacy and safety. American Journal of Obstetrics and Gynecology, 200(3), 238e1–238e10. CrossRef
Pristiq [package insert]. (2008). Philadelphia, PA: Wyeth Pharmaceuticals Inc.
Archer, D. F., Seidman, L., Constantine, G. D., Pickar, J. H., & Olivier, S. (2009). A double-blind, randomly assigned, placebo-controlled study of desvenlafaxine efficacy and safety for the treatment of vasomotor symptoms associated with menopause. American Journal of Obstetrics and Gynecology, 200(2), 172.e1–172.e10. CrossRef
The Greene Climacteric Scale. http://www.menopausematters.co.uk/greenscore.php. Accessed September 16, 2010.
Cunningham, W. E., Hays, R. D., Burton, T. M., & Kington, R. S. (2000). Health status measurement performance and health status differences by age, ethnicity, and gender: Assessment in the medical outcomes study. Journal of Health Care for the Poor and Underserved, 11(1), 58–76. PubMed
Nunnally, J. C., & Bernstein, I. H. (1994). Psychometric theory (3rd ed.). New York, NY: McGraw-Hill.
Streiner, D. L., & Norman, G. R. (Eds.). (2003). Health measurement scales: A practical guide to their development and use (3rd ed.). Oxford: Oxford University Press.
McNair, D. M., Lorr, J., & Droppleman, L. F. (2003). Profile of mood states. Technical update. North Tonawanda, NY: Multi-Health Systems.
Hinkle, D. E., Wiersma, W., & Jurs, S. G. (1988). Applied statistics for the behavioral sciences (2nd ed.). Boston, MA: Houghton Mifflin Company.
Joreskog, K. (2005). Structural equation modeling with ordinal variables using LISREL. Scientific Software International. http://www.ssicentral.com/lisrel/techdocs/ordinal.pdf. Accessed September 16, 2010.
Kenny, D. A. Structural equation modeling. http://davidakenny.net/cm/causalm.htm Accessed September 16, 2010.
Kline, R. B. (2005). Principles and practice of structural equation modeling (2nd ed.). New York, NY: The Guilford Press.
Schriesheim, C. A., Eisenbach, R. J., & Hill, K. D. (1991). The effect of negation and polar opposite item reversals on questionnaire reliability and validity: An experimental investigation. Educational and Psychological Measurement, 51(1), 67–78. CrossRef
Federal Drug Administration. (2009). Guidance for industry on patient-reported outcome measures: Use in medical product development to support labeling claims. Federal Register, 74(235), 65132–65133.
MacLennan, A. H., Broadbent, J. L., Lester, S., & Moore, V. (2004). Oral oestrogen and combined oestrogen/progestogen therapy versus placebo for hot flushes. Cochrane Database of Systematic Reviews, (4), CD002978.
- Validation of POMS questionnaire in postmenopausal women
Kathleen W. Wyrwich
- Springer Netherlands